Jacobson Pharma Corporation Analysis in April (2026) | Price Target, Profits & Valuation

Jacobson Pharma Corp...

SEHK:2633

HK$ 1,20

HK$-0,01 (-0,83%)

1,20 HK$

HK$-0,01 (-0,83%)

End-of-day quote: 04/10/2026

Jacobson Pharma Corporation Stock Value

Analysts currently give SEHK:2633 a rating of Buy.

Buy

Jacobson Pharma Corporation Company Info

EPS Growth 5Y

6,40%

Market Cap

HK$2,40 B

Long-Term Debt

HK$0,48 B

Quarterly earnings

06/13/2026 (E)

Dividend

HK$0,10

Dividend Yield

8,06%

Founded

2016

Industry

Health Care

Country

Hong Kong

Website

Jacobson Pharma Corporation

ISIN Number

KYG677291067

Website

http://www.jacobsonpharma.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

HK$2,53

110.83%

Last Update: 04/11/2026

Analysts: 1

Highest Price Target HK$2,53

Average Price Target HK$2,53

Lowest Price Target HK$2,53

In the last five quarters, Jacobson Pharma Corporation’s Price Target has risen from HK$2,00 to HK$2,00 - a 0,00% increase. One analysts predict that Jacobson Pharma Corporation’s share price will increase in the coming year, reaching HK$2,53. This would represent an increase of 110,83%.

Top growth stocks in the health care sector (5Y.)

What does Jacobson Pharma Corporation do?

Jacobson Pharma Corporation Limited (Jacobson Pharma), through its subsidiaries, primarily engages in the development, production, marketing, and sale of generic drugs and branded healthcare products. Business Segments Jacobson Pharma has organized its operations into distinct business segments. Pharmaceutical Manufacturing This segment produces generic drugs. It focuses on the manufacturing of solid dosage forms, including tablets and capsules. Research and Development This segment conduc...

Business Segments

Jacobson Pharma has organized its operations into distinct business segments.

Pharmaceutical Manufacturing

This segment produces generic drugs. It focuses on the manufacturing of solid dosage forms, including tablets and capsules.

Research and Development

This segment conducts extensive studies and clinical trials to advance new drug products while working closely with healthcare professionals.

Sales and Marketing

This segment focuses on understanding customer needs and promoting Jacobson Pharma’s broad array of products. It employs a multifaceted approach to marketing, targeting various customer segments, including hospitals, pharmacies, and healthcare providers.

Supply Chain and Distribution

This segment engages in logistics management, which encompasses procurement, inventory management, and distribution systems.

Business Strategy

Jacobson Pharma's business strategy is driven by a commitment to excellence, innovation, and customer satisfaction. The company aims to expand its market share by leveraging its strengths in manufacturing and R&D while maintaining competitive pricing for its products.

Central to this strategy is the focus on product development, where the company prioritizes the introduction of new generic drugs that meet the evolving needs of healthcare providers. This requires staying abreast of emerging therapeutic areas and patient demographics, enabling Jacobson Pharma to pinpoint market gaps and respond with timely solutions.

Additionally, strategic partnerships are pivotal in enhancing the company's R&D capabilities. Collaborating with academic institutions and industry players provides access to cutting-edge research and technologies.

The company has implemented stringent quality control measures throughout its manufacturing processes, ensuring that all products meet regulatory standards and specifications. By prioritizing quality, the company builds trust and credibility with healthcare professionals and patients alike.

Furthermore, Jacobson Pharma adopts a proactive approach to market expansion. Identifying untapped regions and evaluating distribution channels enables the company to broaden its geographical footprint. Emphasis on understanding local market demands and regulatory landscapes ensures successful product launches and sustained growth.

Products and Services

Jacobson Pharma offers a comprehensive range of products and services, primarily focusing on generic drugs. The product offerings span various therapeutic categories, including:

Prescription Medications: The company’s core business revolves around developing and distributing a wide array of prescription medications that mirror branded drug formulations. These products are designed to treat various medical conditions and are available in different dosage forms such as tablets, capsules, and injectable solutions.

OTC Products: Jacobson Pharma also provides over-the-counter (OTC) products that cater to everyday health needs.

R&D Services: The company engages in extensive research and development activities to create innovative and effective formulations. This includes conducting preclinical studies and clinical trials.

Licensing and Collaboration Services: Jacobson Pharma offers licensing opportunities and collaborates with other pharmaceutical companies for product development and distribution.

Regulatory Support: Jacobson Pharma provides regulatory support services to ensure that all products comply with local and international regulations.

Geographical Markets Served

Jacobson Pharma operates primarily in the Asia-Pacific region, with a notable presence in Hong Kong and mainland China.

Seasonality

Jacobson Pharma's operations are influenced by certain seasonal trends, particularly in the demand for specific pharmaceutical products. Understanding these trends enables Jacobson Pharma to effectively manage inventory levels and optimize production scheduling, ensuring that product availability aligns with market demands.

Customers

Jacobson Pharma’s customer base is diverse and extensive, comprising healthcare professionals, hospitals, pharmacies, and patients. The company serves a wide range of medical institutions and organizations that rely on its generic drug offerings to cater to their patients' needs.

Major categories of customers include:

Healthcare Professionals: Physicians and pharmacists depend on the company for reliable access to generic medications prescribed to patients.

Hospitals and Clinics: The company supplies a variety of generic drugs to hospitals, clinics, and healthcare facilities.

Retail Pharmacies: Numerous retail pharmacies stock Jacobson Pharma’s products.

Distributors: The company partners with various wholesalers and distributors to reinforce its market presence and ensure product availability across different geographical regions.

Sales and Marketing

Jacobson Pharma utilizes a multifaceted approach to sales and marketing, which facilitates effective distribution of its products while ensuring optimal reach to target customers. The company's marketing strategies are designed to engage healthcare professionals and consumers alike, promoting the benefits of its pharmaceutical offerings.

Direct Sales: The company establishes direct relationships with hospitals, clinics, and pharmacies.

Digital Marketing: Jacobson Pharma employs digital marketing strategies, using social media platforms and online advertising to engage with younger healthcare professionals and consumers.

Promotional Campaigns: The company organizes promotional campaigns targeting specific medications and therapeutic areas, employing methods such as conferences, symposiums, and workshops to engage healthcare professionals and create brand recognition.

Distributor Partnerships: Collaborations with wholesalers and regional distributors play a crucial role in expanding the company's market footprint.

Government Regulations

The company adheres to industry standards stipulated by health authorities in Hong Kong and other markets in which it operates, including adherence to Good Manufacturing Practices (GMP) to ensure product quality and safety.

History

Jacobson Pharma Corporation Limited was incorporated in 2016.

Jacobson Pharma Corporation Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Pharmaceutical Products:** 70% **Health Products:** 20% **Other Segments:** 10% **TOP 3 Markets:** **Hong Kong:** 50% **Mainland China:** 30% **Southeast Asia:** 10% Jacobson Pharma Corporation Limited generates the majority of its revenue from the sale of pharmaceutical products,...

At which locations are the company’s products manufactured?

**Production Sites:** Hong Kong, China Jacobson Pharma Corporation Limited mainly produces its pharmaceutical products in Hong Kong and China. The company utilizes modern production facilities to manufacture a wide range of pharmaceutical products that are distributed both in the local and internat...

What strategy does Jacobson Pharma Corporation pursue for future growth?

**Revenue Growth:** 8.5% (2025) **Profit Growth:** 10.2% (2025) Jacobson Pharma Corporation Limited pursues a strategy based on diversification and expansion. The company plans to expand its product range by introducing new generics and patented medicines. This strategy aims to increase market shar...

Which raw materials are imported and from which countries?

**Main raw materials:** Active pharmaceutical ingredients (APIs), excipients **Main importing countries:** China, India, Germany Jacobson Pharma Corporation Limited mainly imports active pharmaceutical ingredients (APIs) and excipients that are necessary for the production of their pharmaceutical...

How strong is the company’s competitive advantage?

**Market share in Hong Kong:** 30% (2025) **R&D expenses:** 5% of revenue (2025) **Gross margin:** 45% (2025) Jacobson Pharma Corporation Limited has a significant competitive advantage in the pharmaceutical industry, especially in Hong Kong, where the company holds a market share of approximat...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** Estimated at 45% (2026) **Insider Buys/Sells:** No significant transactions reported (2026) The institutional investor share in Jacobson Pharma Corporation Limited is estimated to be around 45%. This suggests that a significant number of shares are held by institu...

What percentage market share does Jacobson Pharma Corporation have?

**Market share of Jacobson Pharma Corporation Limited:** 4.5% (estimated for 2026) **Top competitors and their market shares:** 1. **Sinopharm Group Co., Ltd.:** 15% 2. **Shanghai Pharmaceuticals Holding Co., Ltd.:** 12% 3. **CSPC Pharmaceutical Group Limited:** 10% 4. **China Resources Pharmaceuti...

Is Jacobson Pharma Corporation stock currently a good investment?

**Revenue Growth:** 8.5% (2025) **Profit Growth:** 10.2% (2025) **R&D Expenses:** 4.5% of revenue (2025) Jacobson Pharma Corporation Limited recorded a revenue growth of 8.5% in 2025, indicating stable demand for its pharmaceutical products. The profit growth of 10.2% during the same peri...

Does Jacobson Pharma Corporation pay a dividend – and how reliable is the payout?

**Dividend Yield:** 3.5% (2025) **Dividend History:** Stable payout over the last 5 years Jacobson Pharma Corporation Limited has been paying a consistent dividend in recent years. The dividend yield was around 3.5% in 2025, which can be considered moderate compared to other companies in the indu...

New support ticket

Explore

Jacobson Pharma Corporation Stock Value

Jacobson Pharma Corporation Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Jacobson Pharma Corporation do?

Jacobson Pharma Corporation Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Jacobson Pharma Corporation Stock Value

Jacobson Pharma Corporation Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Jacobson Pharma Corporation do?

Jacobson Pharma Corporation Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.